Literature DB >> 16132038

Influence of the cytoplasmic domain of E-cadherin on endogenous N-cadherin expression in malignant melanoma.

S Kuphal1, A K Bosserhoff.   

Abstract

E-cadherin is known to be an important molecule in epithelial-mesenchymal transition (EMT). Malignant transformation of melanocytes frequently attends with loss of E-cadherin expression and induction of expression of mesenchymal molecules like N-cadherin. The switch of the cadherin class is an interesting phenomenon of melanoma cells and in EMT in general. Therefore, we analysed the capacity of E-cadherin to regulate expression of N-cadherin in melanocytic cells. Our experiments revealed that melanoma cells downregulate endogenous N-cadherin expression after transient transfection of full-length E-cadherin, but also of the cytoplasmic domain of E-cadherin. Therefore, we concluded that the extracellular domain of E-cadherin and cell-cell contacts are not necessary for negative regulation of N-cadherin. Melanoma cells re-expressing full-length or cytoplasmatic E-cadherin have reduced NFkappaB activity in comparison to mock-transfected cells. Downregulation of NFkappaB activity, either directly or by re-expression of E-cadherin, led to a suppression of N-cadherin promoter activity and N-cadherin expression. Consequently, an NFkappaB-binding site in the N-cadherin promoter was characterized. In summary, our results suggest that N-cadherin is directly regulated by E-cadherin. Loss of E-cadherin induces NFkappaB activity and N-cadherin expression in tumorigenic EMT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16132038     DOI: 10.1038/sj.onc.1209054

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  30 in total

Review 1.  Molecular pathology of cutaneous melanoma.

Authors:  Léon C van Kempen; Margaret Redpath; Caroline Robert; Alan Spatz
Journal:  Melanoma Manag       Date:  2014-12-04

2.  MiR-506 inhibits multiple targets in the epithelial-to-mesenchymal transition network and is associated with good prognosis in epithelial ovarian cancer.

Authors:  Yan Sun; Limei Hu; Hong Zheng; Marina Bagnoli; Yuhong Guo; Rajesha Rupaimoole; Cristian Rodriguez-Aguayo; Gabriel Lopez-Berestein; Ping Ji; Kexin Chen; Anil K Sood; Delia Mezzanzanica; Jinsong Liu; Baocun Sun; Wei Zhang
Journal:  J Pathol       Date:  2014-11-06       Impact factor: 7.996

3.  Magnetic resonance imaging of iron-oxide labeled SK-Mel 28 human melanoma cells in the chick embryo using a clinical whole body MRI scanner.

Authors:  M Oppitz; J Pintaske; R Kehlbach; F Schick; G Schriek; C Busch
Journal:  MAGMA       Date:  2006-12-19       Impact factor: 2.310

Review 4.  Insulin-like growth factor system and sporadic malignant melanoma.

Authors:  Ettore Capoluongo
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

5.  LPP inhibits collective cell migration during lung cancer dissemination.

Authors:  S Kuriyama; M Yoshida; S Yano; N Aiba; T Kohno; Y Minamiya; A Goto; M Tanaka
Journal:  Oncogene       Date:  2015-06-01       Impact factor: 9.867

6.  Evaluation of molecular markers of mesenchymal phenotype in melanoma.

Authors:  Leann M Mikesh; Manish Kumar; Gulsun Erdag; Kevin T Hogan; Kerrington R Molhoek; Marty W Mayo; Craig L Slingluff
Journal:  Melanoma Res       Date:  2010-12       Impact factor: 3.599

Review 7.  Linking the history of radiation biology to the hallmarks of cancer.

Authors:  Mary-Keara Boss; Robert Bristow; Mark W Dewhirst
Journal:  Radiat Res       Date:  2014-05-08       Impact factor: 2.841

8.  Retinoic acid receptor beta2 re-expression and growth inhibition in thyroid carcinoma cell lines after 5-aza-2'-deoxycytidine treatment.

Authors:  F Y Miasaki; A Vivaldi; R Ciampi; L Agate; P Collecchi; A Capodanno; A Pinchera; R Elisei
Journal:  J Endocrinol Invest       Date:  2008-08       Impact factor: 4.256

9.  Trypsin-induced proteome alteration during cell subculture in mammalian cells.

Authors:  Hsiang-Ling Huang; Hsiang-Wei Hsing; Tzu-Chia Lai; Yi-Wen Chen; Tian-Ren Lee; Hsin-Tsu Chan; Ping-Chiang Lyu; Chieh-Lin Wu; Ying-Chieh Lu; Szu-Ting Lin; Cheng-Wen Lin; Chih-Ho Lai; Hao-Teng Chang; Hsiu-Chuan Chou; Hong-Lin Chan
Journal:  J Biomed Sci       Date:  2010-05-11       Impact factor: 8.410

10.  PPAR gamma regulates MITF and beta-catenin expression and promotes a differentiated phenotype in mouse melanoma S91.

Authors:  Maja Grabacka; Wojciech Placha; Krystyna Urbanska; Piotr Laidler; Przemysław M Płonka; Krzysztof Reiss
Journal:  Pigment Cell Melanoma Res       Date:  2008-04-26       Impact factor: 4.693

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.